Navigation Links
Modigene to Present at the BIO-Europe Spring(R) 2009 Conference
Date:3/10/2009

NES-ZIONA, Israel, March 10 /PRNewswire/ -- Modigene Inc. (OTC Bulletin Board: MODG), a biopharmaceutical company developing a long-acting human growth hormone and other proprietary longer-acting versions of already approved therapeutic proteins, today announced that CEO Avri Havron will present at the upcoming BIO-Europe Spring(R) 2009 Conference at 10:00 AM (local time) on March 17, 2009. The conference will be held at the Milano Convention Center in Milan, Italy from March 16-18, 2009.

For more information about the BIO-Europe Spring(R) 2009 Conference, visit http://www.ebdgroup.com/bes/

ABOUT MODIGENE

Modigene Inc. is a biopharmaceutical company applying its patented CTP technology to develop longer-acting, proprietary versions of already approved therapeutic proteins that currently generate billions of dollars in annual global sales. The CTP technology is applicable to virtually all proteins, and Modigene is currently developing long-acting versions of human growth hormone, interferon beta and erythropoietin, which are in late preclinical development, as well as GLP-1. For more information on Modigene, visit www.modigeneinc.com.

    MODIGENE CONTACT:                         MEDIA CONTACT:
    Shai Novik, President                     Barbara Lindheim
    Modigene Inc.                             GendeLLindheim BioCom Partners
    Tel: +1 866 644-7811                      +1 212 918-4650
    Email: shai@modigeneinc.com


'/>"/>
SOURCE Modigene Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Modigene Sets Record Date for Annual Meeting of Shareholders
2. Modigene Awarded Second-Year Grant by Israeli Government to Support Development of Its Longer-Acting Human Growth Hormone
3. Modigene to Present at the UBS Global Life Sciences Conference
4. Modigene to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
5. Modigene Announces Closing of $12 Million Financing by Members of The Frost Group
6. Modigene to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
7. Modigene to Present at the Roth 2007 New York Investor Conference
8. NxStage to Present at the Cowen and Company 29th Annual Healthcare Conference
9. WaferGen to Present Data on SmartChip(TM) Real-Time PCR System at Cambridge Healthtech Institutes Quantitative PCR Conference
10. Kendle to Present at Upcoming Barclays Capital and Raymond James Conferences
11. Cynvec LLC(SM) to Present at the Cowen and Company 29th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... (ADC) therapeutics, today confirmed licensing rights that give it exclusive global access ... developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, an ...
(Date:10/10/2017)... ... , ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... The event entitled “Stem Cells and Their Regenerative Powers,” was held on August ... MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic ...
(Date:10/10/2017)... Calif. , Oct. 10, 2017 SomaGenics ... from the NIH to develop RealSeq®-SC (Single Cell), expected ... for profiling small RNAs (including microRNAs) from single cells ... Program highlights the need to accelerate development of approaches ... "New techniques for measuring levels ...
Breaking Biology Technology:
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, 2017, ... the Genome hackathon at Microsoft,s headquarters in ... competition will focus on developing health and wellness apps ... Hack the Genome is the first hackathon ... The world,s largest companies in the genomics, tech and ...
Breaking Biology News(10 mins):